نتایج جستجو برای: پروبیوتیک abt 10

تعداد نتایج: 1019339  

Journal: :Antimicrobial agents and chemotherapy 2001
M J Mitten J Meulbroek M Nukkala L Paige K Jarvis A Oleksijew A Tovcimak L Hernandez J D Alder P Ewing Y S Or Z Ma A M Nilius K Mollison R K Flamm

ABT-773 is a novel ketolide effective against antibacterial-resistant respiratory tract pathogens. The pharmacokinetic profile of ABT-773 was studied in rats and consisted of a mean peak concentration in plasma of 1.07 microg/ml and an area under the concentration-time curve (AUC) of 12.03 microg. h/ml when the compound was delivered at a dose of 25 mg/kg of body weight. It concentrated in rat ...

Journal: :Cancer research 2015
Sarah E Alford Anisha Kothari Floris C Loeff Joshua M Eichhorn Nandini Sakurikar Henriette M Goselink Robert L Saylors Inge Jedema J H Frederik Falkenburg Timothy C Chambers

BH3 mimetic drugs may be useful to treat acute lymphoblastic leukemia (ALL) but the sensitivity of primary tumor cells has not been fully evaluated. Here, B-lineage ALL cell cultures derived from a set of primary tumors were studied with respect to sensitivity to the BH3 mimetics ABT-263 and ABT-199 and to Bcl-2 dependence and function. These ALL cells each expressed high levels of Bcl-2 and ex...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Vinicio Carloni Francesco Vizzutti Pietro Pantaleo

PURPOSE Treatment of hepatocellular carcinoma raised on cirrhotic liver represents a major endeavor because surgery and chemotherapeutic management fail to improve the clinical course of the disease. Chemoprevention could represent an important means to inhibit the process of hepatocarcinogenesis. Farnesyltransferase inhibitors are a class of drugs blocking the growth of tumor cells with minima...

Journal: :The Journal of pharmacology and experimental therapeutics 2012
Timothy A Esbenshade Kaitlin E Browman Thomas R Miller Kathleen M Krueger Victoria Komater-Roderwald Min Zhang Gerard B Fox Lynne Rueter Holly M Robb Richard J Radek Karla U Drescher Thomas A Fey R Scott Bitner Kennan Marsh James S Polakowski Chen Zhao Marlon D Cowart Arthur A Hancock James P Sullivan Jorge D Brioni

Blockade of the histamine H(3) receptor (H(3)R) enhances central neurotransmitter release, making it an attractive target for the treatment of cognitive disorders. Here, we present in vitro and in vivo pharmacological profiles for the H(3)R antagonist 2-[4'-((3aR,6aR)-5-methyl-hexahydro-pyrrolo[3,4-b]pyrrol-1-yl)-biphenyl-4-yl]-2H-pyridazin-3-one (ABT-288). ABT-288 is a competitive antagonist w...

2015
Stefano Iacovelli Maria Rosaria Ricciardi Matteo Allegretti Simone Mirabilii Roberto Licchetta Paola Bergamo Cinzia Rinaldo Ann Zeuner Robin Foà Michele Milella James A. McCubrey Alberto M. Martelli Agostino Tafuri

Several chemo-resistance mechanisms including the Bcl-2 protein family overexpression and constitutive activation of the PI3K/Akt/mTOR signaling have been documented in acute lymphoblastic leukemia (ALL), encouraging targeted approaches to circumvent this clinical problem. Here we analyzed the activity of the BH3 mimetic ABT-737 in ALL, exploring the synergistic effects with the mTOR inhibitor ...

2007
Roie Zivan Moshe Zazone Amnon Meisels

Ordering heuristics are a powerful tool in CSP search algorithms. Among the most successful ordering heuristics are heuristics which enforce a fail first strategy by using the min-domain property [HE80, BR96, SG98, Dec 03]. Ordering heuristics have been introduced recently to Asynchronous backtracking (ABT), for distributed constraints satisfaction (DisCSP) [ZM05]. However, the pioneering study...

2016
Kevin H. Lin Peter S. Winter Abigail Xie Cullen Roth Colin A. Martz Elizabeth M. Stein Grace R. Anderson Jennifer P. Tingley Kris C. Wood

ABT-199, a potent and selective small-molecule antagonist of BCL-2, is being clinically vetted as pharmacotherapy for the treatment of acute myeloid leukemia (AML). However, given that prolonged monotherapy tends to beget resistance, we sought to investigate the means by which resistance to ABT-199 might arise in AML and the extent to which those mechanisms might be preempted. Here we used a pa...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2014
Rowan A Stringer Eckhard Weber Bruno Tigani Paul Lavan Stephen Medhurst Bindi Sohal

The simultaneous effects of the cytochrome P450 inhibitor 1-aminobenzotriazole (ABT) on inhibition of in vivo metabolism and gastric emptying were evaluated with the test compound 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole(NVS-CRF38), a novel corticotropin releasing factor receptor 1 (CRF1) antagonist with low water solubility, and the...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2008
Vinay Parikh Kingson Man Michael W Decker Martin Sarter

Because modulation of cortical cholinergic neurotransmission has been hypothesized to represent a necessary mechanism mediating the beneficial cognitive effects of nicotine and nicotinic acetylcholine receptor (nAChR) subtype-selective agonists, we used choline-sensitive microelectrodes for the real-time measurement of ACh release in vivo, to characterize cholinergic transients evoked by nicoti...

Journal: :Molecular cancer therapeutics 2009
Michelle J Clarke Evan A Mulligan Patrick T Grogan Ann C Mladek Brett L Carlson Mark A Schroeder Nicola J Curtin Zhenkun Lou Paul A Decker Wenting Wu E Ruth Plummer Jann N Sarkaria

Resistance to temozolomide and radiotherapy is a major problem for patients with glioblastoma but may be overcome using the poly(ADP-ribose) polymerase inhibitor ABT-888. Using two primary glioblastoma xenografts, the efficacy of ABT-888 combined with radiotherapy and/or temozolomide was evaluated. Treatment with ABT-888 combined with temozolomide resulted in significant survival prolongation (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید